None listed
Conditions
Brief summary
The research study aims to understand if patients' attitudes towards appropriate care for their Age-related Macular Degeneration can be altered based on the type of education they receive. Two different approaches to providing patient education will be provided. This study will help us understand what type of education helps patients accept care that is best for them. If one approach to education is found to be better, we will share our educational approach with other eye health professionals so that they can help their patients make better care decisions too.
Interventions
Patient-determined education has content designed by patients and clinicians: Attending clinician will deliver Patient-determined Education package during routine baseline clinical eye exam: - Will involve 5 to 10 minutes of face-to-face education on stage of disease diagnosed at this visit plus relevant treatments appropriate to stage (Ex. smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections). Conversations guided primarily by patient questions and interest. - May involve material to take-home to read. Material (one page brochure) depends on stage of disease diagnosed at this visit plus relevant treatments appropriate to stage (Ex. smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections) based on most recent published evidence. Take home material offered determined by patient interest and questions. - May be supported by follow-up text message reminders monthly for 6 months post-enrolment. Reminders will focus on treatments relevant to stage of disease diagnosed and may address smoking cessation, use of Amsler Grid, use of eye health supplements or eye injections. Text reminders enrolled determined by patient questions and interests.
Sponsors
Study design
Eligibility
Inclusion criteria
Adults (age greater than 50) diagnosed at the Centre for Eye Health between with: • Large drusen at the macula in either eye, • Pigmentary abnormalities associated with at least medium sized drusen in either eye, • Late AMD (geographic atrophy) • Late AMD (macular neovascularization)
Exclusion criteria
Potential participants must be able to communicate effectively in English and be legally capable to provide formal written direct consent to participate. Potential participants intending to move outside of the study catchment area (NSW) over the duration of study conduct will not be eligible. Patients with other co-morbid ocular disease (Ex. glaucoma) requiring treatment will also not be eligible to participate.